JinkoSolar (JKS) Q2 2026 Earnings Call Transcript

JinkoSolar reported Q2 2026 revenue of $1.82B (down 31.3% YoY; +0.9% QoQ), with gross margin falling to 4.2% (from 8.3% in Q1) and net loss widening to RMB 697.3M ($102.8M). Management lowered full-year module shipment guidance to 60–70GW (from prior higher targets) to prioritize profitability and cash flow, while Q3 module shipments are guided to 15–17GW. Cash and equivalents declined to ~$2.5B (from $3.3B in Q1) and operating loss margin widened to 11.6%; the board declared a $1.50 per ADS dividend. Management attributed margin pressure to lower average selling prices, elevated ramp-up costs for Tiger Neo 3.0, and slower domestic installations under renewable pricing changes.

Analysis

The key mechanism is not just weak solar pricing; it is a forced re-rating of who can still earn acceptable returns in a structurally oversupplied industry. JKS is signaling it will sacrifice volume to protect cash and mix, which is rational, but that also means lower utilization, fewer fixed-cost dollars absorbed, and a harder path to margin recovery if ASPs only bounce modestly. The most durable beneficiaries are higher-bankability, policy-favored producers and local-content players like FSLR, while subscale/global-china export competitors should see the most pressure as trade barriers and efficiency standards raise the cost of doing business.

Near term, the market may over-focus on sequential ASP recovery and miss that this is still a low-quality earnings set-up: operating losses widened, credit provisions are rising, and cash is being consumed even after asset sales. The balance sheet is not in acute distress, but leverage leaves less room for another downcycle; any surprise in receivables, inventory markdowns, or project delays would hit equity quickly over the next 1-2 quarters. The 2027 efficiency standard is a real catalyst, but it is a months-to-years story, not a day-trade; until then, the sector remains hostage to pricing discipline that is difficult to enforce.

Contrarian view: the market may be underestimating two offsets — JKS’s premium mix/ESS ramp and the monetization of its investment portfolio — which can cushion reported earnings and support a sum-of-the-parts case. But those are not clean operating wins, and the bigger question is whether investors should pay for non-core gains in a cyclical manufacturing name. If Q3 gross margin fails to improve meaningfully despite better mix and higher input prices, the thesis that profitability is troughing will be falsified.

Key Decisions for Investors

• Short JKS on post-earnings strength or any rally toward prior support; thesis is 1-3 month downside from continued low utilization, leverage, and weak operating leverage. Cover if Q3 gross margin reaccelerates meaningfully or if management raises shipment guidance again.
• Pair trade: long FSLR / short JKS for a 3-6 month policy-spread trade. FSLR should capture U.S. localization, tariff pass-through, and higher pricing power, while JKS faces ongoing trade barriers and pricing pressure; thesis breaks if U.S. module pricing compresses enough to impair demand materially.
• Buy JKS downside via 1-2 quarter put spreads rather than outright puts if liquidity is a concern. The clean catalyst is any miss on Q3 margin guidance or evidence that the ASP rebound is less than management implies.
• Watchlist alert on JKS for cash burn and working-capital metrics over the next two quarters: if cash stays below $2B or net debt keeps rising despite asset sales, the equity multiple should compress further.
• If seeking a contrarian long, consider only a small tactical position in JKS after a sharp selloff, contingent on verified Q3 gross margin improvement and stable receivables; otherwise the risk/reward still favors staying defensive.